Patent · US Expired

Expression in non-tumoral human lymphoblastoid lines with an integrative vector

US5789247A · kind A · utility

54Cited by
0References
14Claims
0Family size

Inventors

Key dates

Filing dateOct 12, 1994
Grant dateAug 4, 1998
Priority date
Expiry dateOct 12, 2014

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2840/20
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A plasmid vector designed for transforming lymphoblastoid cells, immortalized by Epstein Barr virus, for producing heterologous proteins, which comprises the bacterial DNA elements required for its amplification together with the following DNA fragments: PA1 the DNA elements which constitute an expression cassette allowing the insertion of a heterologous DNA to be expressed in the human lymphoblastoid cells, PA1 the Adenovirus 5 derived DNA sequence encoding the VA I and VA II RNA aimed at optimizing the messenger RNA translation, PA1 a gene engineered to be efficient as a selective marker in eukaryotic cells, and PA1 DNA segments selected for their property to promote plasmid DNA integration into the cell chromosome DNA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.